{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:08:11Z","timestamp":1793149691339,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis therapy is still limited to treatment of the underlying infection and supportive measures. To date, various sepsis subtypes were proposed, but therapeutic options addressing the molecular changes of sepsis were not identified. With the aim of a future individualized therapy, we used machine learning (ML) to identify clinical phenotypes and their temporal development in a prospective, multicenter sepsis cohort and characterized them using plasma proteomics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Routine clinical data and blood samples were collected from 384 patients. Sepsis phenotypes were identified based on clinical measurements and plasma samples from 301 patients were analyzed using mass spectrometry. The obtained data were evaluated in relation to the phenotypes, and supervised ML models were developed enabling prospective phenotype classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three sepsis phenotypes were identified. Cluster C was characterized by the highest disease severity and multi-organ failure with leading liver failure. Cluster B showed relevant organ failure, with renal damage being particularly prominent in comparison to cluster A. Time course analysis showed a strong association of cluster C with mortality, while patients in cluster B were likely to change the cluster until day 4. The plasma proteome reflected the clinical features of the phenotypes and showed gradual consumption of complement and coagulation factors with increasing sepsis severity. Supervised ML models allowed the assignment of patients based on only seven widely available features (alanine transaminase (ALT), aspartate transaminase (AST), base excess (BE), international normalized ratio of thrombin time (INR), diastolic arterial blood pressure, systolic arterial blood pressure (BPdia, BPsys) and activated partial thromboplastin time (aPTT)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The identified clinical phenotypes reflected varying degrees of sepsis severity and were mirrored in the plasma proteome. Proteomic profiling offered novel insights into the molecular mechanisms underlying sepsis and enabled a deeper characterization of the identified phenotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-025-02628-3","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:26:47Z","timestamp":1756366007000},"page":"2779-2793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Machine learning identifies clinical sepsis phenotypes that translate to the plasma proteome"],"prefix":"10.1007","volume":"53","author":[{"given":"Thilo","family":"Bracht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Palmowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Schork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rahmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Unterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Koos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Rump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Ziehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Limper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Henzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan Felix","family":"Ehrentraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"von Groote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Marcus-Alic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eisenacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Adamzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmuth","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"11","key":"2628_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y.","journal-title":"Intensive Care Med"},{"issue":"10219","key":"2628_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"2628_CR3","doi-asserted-by":"publisher","unstructured":"Marti-Carvajal AJ, Sola I, Lathyris D, Cardona AF. Human Recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev. 2012;3CD004388. https:\/\/doi.org\/10.1002\/14651858.CD004388.pub5.","DOI":"10.1002\/14651858.CD004388.pub5"},{"issue":"10","key":"2628_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","volume":"209","author":"B Teja","year":"2024","unstructured":"Teja B, Berube M, Pereira TV, Law AC, Schanock C, Pang B, et al. Effectiveness of fludrocortisone plus hydrocortisone versus hydrocortisone alone in septic shock: A systematic review and network Meta-Analysis of randomized controlled trials. Am J Respir Crit Care Med. 2024;209(10):1219\u201328. https:\/\/doi.org\/10.1164\/rccm.202310-1785OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2628_CR5","doi-asserted-by":"publisher","first-page":"e10128","DOI":"10.15252\/emmm.201810128","volume":"12","author":"JM Cavaillon","year":"2020","unstructured":"Cavaillon JM, Singer M, Skirecki T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med. 2020;12(4):e10128. https:\/\/doi.org\/10.15252\/emmm.201810128.","journal-title":"EMBO Mol Med"},{"key":"2628_CR6","doi-asserted-by":"publisher","unstructured":"Papathanakos G, Andrianopoulos I, Xenikakis M, Papathanasiou A, Koulenti D, Blot S, et al. Clinical sepsis phenotypes in critically ill patients. Microorganisms. 2023;11(9). https:\/\/doi.org\/10.3390\/microorganisms11092165.","DOI":"10.3390\/microorganisms11092165"},{"issue":"20","key":"2628_CR7","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003\u201317. https:\/\/doi.org\/10.1001\/jama.2019.5791.","journal-title":"JAMA"},{"issue":"11","key":"2628_CR8","doi-asserted-by":"publisher","first-page":"e1176","DOI":"10.1097\/CCE.0000000000001176","volume":"6","author":"MA Slim","year":"2024","unstructured":"Slim MA, van Amstel RBE, Muller MCA, Cremer OL, Vlaar APJ, van der Poll T, et al. Clinical subtype trajectories in sepsis patients admitted to the ICU: A secondary analysis of an observational study. Crit Care Explorations. 2024;6(11):e1176. https:\/\/doi.org\/10.1097\/CCE.0000000000001176.","journal-title":"Crit Care Explorations"},{"issue":"8","key":"2628_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"2628_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02325-7","author":"A Witowski","year":"2024","unstructured":"Witowski A, Palmowski L, Rahmel T, Nowak H, Ehrentraut SF, Putensen C, et al. Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 sepsis cohort. Infection. 2024. https:\/\/doi.org\/10.1007\/s15010-024-02325-7.","journal-title":"Infection"},{"issue":"1","key":"2628_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s13054-023-04713-1","volume":"27","author":"M Unterberg","year":"2023","unstructured":"Unterberg M, Ehrentraut SF, Bracht T, Wolf A, Haberl H, von Busch A, et al. Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis. Crit Care. 2023;27(1):417. https:\/\/doi.org\/10.1186\/s13054-023-04713-1.","journal-title":"Crit Care"},{"key":"2628_CR12","doi-asserted-by":"publisher","unstructured":"Bracht T, Kleefisch D, Schork K, Witzke KE, Chen W, Bayer M, et al. Plasma proteomics enable differentiation of lung adenocarcinoma from chronic obstructive pulmonary disease (COPD). Int J Mol Sci. 2022;23(19). https:\/\/doi.org\/10.3390\/ijms231911242.","DOI":"10.3390\/ijms231911242"},{"issue":"1","key":"2628_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-7439(00)00122-2","volume":"56","author":"QS Xu","year":"2001","unstructured":"Xu QS, Liang YZ. Monte Carlo cross validation. Chemometr Intell Lab. 2001;56(1):1\u201311. https:\/\/doi.org\/10.1016\/S0169-7439(00)00122-2.","journal-title":"Chemometr Intell Lab"},{"key":"2628_CR14","doi-asserted-by":"publisher","first-page":"105508","DOI":"10.1016\/j.ebiom.2024.105508","volume":"111","author":"L Palmowski","year":"2025","unstructured":"Palmowski L, Weber M, Bayer M, Mi Y, Schork K, Eisenacher M, et al. Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohort. EBioMedicine. 2025;111:105508. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105508.","journal-title":"EBioMedicine"},{"issue":"1","key":"2628_CR15","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.jhepr.2021.100391","volume":"4","author":"J Reissing","year":"2022","unstructured":"Reissing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, et al. Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Reports: Innov Hepatol. 2022;4(1):100391. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100391.","journal-title":"JHEP Reports: Innov Hepatol"},{"key":"2628_CR16","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Reviews Disease Primers. 2016;2:16045. https:\/\/doi.org\/10.1038\/nrdp.2016.45.","journal-title":"Nat Reviews Disease Primers"},{"key":"2628_CR17","doi-asserted-by":"publisher","first-page":"i1585","DOI":"10.1136\/bmj.i1585","volume":"353","author":"JE Gotts","year":"2016","unstructured":"Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585. https:\/\/doi.org\/10.1136\/bmj.i1585.","journal-title":"BMJ"},{"issue":"1","key":"2628_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13054-018-2279-3","volume":"22","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Zhang G, Goyal H, Mo L, Hong Y. Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis. Crit Care. 2018;22(1):347. https:\/\/doi.org\/10.1186\/s13054-018-2279-3.","journal-title":"Crit Care"},{"issue":"5","key":"2628_CR19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00134-015-3764-7","volume":"41","author":"DB Knox","year":"2015","unstructured":"Knox DB, Lanspa MJ, Kuttler KG, Brewer SC, Brown SM. Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intensive Care Med. 2015;41(5):814\u201322. https:\/\/doi.org\/10.1007\/s00134-015-3764-7.","journal-title":"Intensive Care Med"},{"issue":"10","key":"2628_CR20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respiratory Med. 2017;5(10):816\u201326. https:\/\/doi.org\/10.1016\/S2213-2600(17)30294-1.","journal-title":"Lancet Respiratory Med"},{"issue":"4","key":"2628_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respiratory Med. 2016;4(4):259\u201371. https:\/\/doi.org\/10.1016\/S2213-2600(16)00046-1.","journal-title":"Lancet Respiratory Med"},{"issue":"1","key":"2628_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13054-024-04990-4","volume":"28","author":"M Bodinier","year":"2024","unstructured":"Bodinier M, Peronnet E, Llitjos JF, Kreitmann L, Brengel-Pesce K, Rimmele T, et al. Integrated clustering of multiple immune marker trajectories reveals different immunotypes in severely injured patients. Crit Care. 2024;28(1):240. https:\/\/doi.org\/10.1186\/s13054-024-04990-4.","journal-title":"Crit Care"},{"issue":"1","key":"2628_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s43856-024-00542-7","volume":"4","author":"JG Chenoweth","year":"2024","unstructured":"Chenoweth JG, Brandsma J, Striegel DA, Genzor P, Chiyka E, Blair PW, et al. Sepsis endotypes identified by host gene expression across global cohorts. Commun Med. 2024;4(1):120. https:\/\/doi.org\/10.1038\/s43856-024-00542-7.","journal-title":"Commun Med"},{"issue":"11","key":"2628_CR24","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54(11):2450\u201364. https:\/\/doi.org\/10.1016\/j.immuni.2021.10.012.","journal-title":"Immunity"},{"issue":"1\u20132","key":"2628_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/prca.201300101","volume":"8","author":"Z Cao","year":"2014","unstructured":"Cao Z, Robinson RA. The role of proteomics in Understanding biological mechanisms of sepsis. Proteom Clin Appl. 2014;8(1\u20132):35\u201352. https:\/\/doi.org\/10.1002\/prca.201300101.","journal-title":"Proteom Clin Appl"},{"issue":"1S Suppl 1","key":"2628_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/SHK.0000000000000698","volume":"47","author":"NK Sharma","year":"2017","unstructured":"Sharma NK, Salomao R. Sepsis through the eyes of proteomics: the progress in the last decade. Shock. 2017;47(1S Suppl 1):17\u201325. https:\/\/doi.org\/10.1097\/SHK.0000000000000698.","journal-title":"Shock"},{"key":"2628_CR27","doi-asserted-by":"publisher","first-page":"733537","DOI":"10.3389\/fimmu.2021.733537","volume":"12","author":"H Miao","year":"2021","unstructured":"Miao H, Chen S, Ding R. Evaluation of the molecular mechanisms of sepsis using proteomics. Front Immunol. 2021;12:733537. https:\/\/doi.org\/10.3389\/fimmu.2021.733537.","journal-title":"Front Immunol"},{"issue":"750","key":"2628_CR28","doi-asserted-by":"publisher","first-page":"eadh0185","DOI":"10.1126\/scitranslmed.adh0185","volume":"16","author":"Y Mi","year":"2024","unstructured":"Mi Y, Burnham KL, Charles PD, Heilig R, Vendrell I, Whalley J, et al. High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response. Sci Transl Med. 2024;16(750):eadh0185. https:\/\/doi.org\/10.1126\/scitranslmed.adh0185.","journal-title":"Sci Transl Med"},{"issue":"16","key":"2628_CR29","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1002\/1873-3468.13881","volume":"594","author":"TE Mollnes","year":"2020","unstructured":"Mollnes TE, Huber-Lang M. Complement in sepsis-when science Meets clinics. FEBS Lett. 2020;594(16):2621\u201332. https:\/\/doi.org\/10.1002\/1873-3468.13881.","journal-title":"FEBS Lett"},{"issue":"0 1","key":"2628_CR30","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.thromres.2014.03.014","volume":"133","author":"F Lupu","year":"2014","unstructured":"Lupu F, Keshari RS, Lambris JD, Coggeshall KM. Crosstalk between the coagulation and complement systems in sepsis. Thromb Res. 2014;133(0 1):S28\u201331. https:\/\/doi.org\/10.1016\/j.thromres.2014.03.014.","journal-title":"Thromb Res"},{"issue":"1","key":"2628_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13054-023-04344-6","volume":"27","author":"AH de Nooijer","year":"2023","unstructured":"de Nooijer AH, Kotsaki A, Kranidioti E, Kox M, Pickkers P, Toonen EJM, et al. Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity. Crit Care. 2023;27(1):63. https:\/\/doi.org\/10.1186\/s13054-023-04344-6.","journal-title":"Crit Care"},{"key":"2628_CR32","doi-asserted-by":"publisher","first-page":"712572","DOI":"10.3389\/fimmu.2021.712572","volume":"12","author":"J Barratt","year":"2021","unstructured":"Barratt J, Weitz I. Complement factor D as a strategic target for regulating the alternative complement pathway. Front Immunol. 2021;12:712572. https:\/\/doi.org\/10.3389\/fimmu.2021.712572.","journal-title":"Front Immunol"},{"issue":"2","key":"2628_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","volume":"24","author":"DC Mastellos","year":"2024","unstructured":"Mastellos DC, Hajishengallis G, Lambris JD. A guide to complement biology, pathology and therapeutic opportunity. Nat Rev Immunol. 2024;24(2):118\u201341. https:\/\/doi.org\/10.1038\/s41577-023-00926-1.","journal-title":"Nat Rev Immunol"},{"key":"2628_CR34","doi-asserted-by":"publisher","unstructured":"Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, et al. The complement system in COVID-19: friend and foe? JCI Insight. 2020;5(15). https:\/\/doi.org\/10.1172\/jci.insight.140711.","DOI":"10.1172\/jci.insight.140711"},{"issue":"4","key":"2628_CR35","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/CCM.0000000000002965","volume":"46","author":"AEW Johnson","year":"2018","unstructured":"Johnson AEW, Aboab J, Raffa JD, Pollard TJ, Deliberato RO, Celi LA, et al. A comparative analysis of sepsis identification methods in an electronic database. Crit Care Med. 2018;46(4):494\u20139. https:\/\/doi.org\/10.1097\/CCM.0000000000002965.","journal-title":"Crit Care Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02628-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:52:35Z","timestamp":1764751955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02628-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02628-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SepsisDataNet.NRW and CovidDataNet.NRW studies were approved by the Ethics Committee of the Medical Faculty of Ruhr-University Bochum (Registration No. 5047\u201314 and 19-6606_6-BR, respectively) or the responsible ethics committee of each respective study center and conducted in accordance with the revised Declaration of Helsinki. Written informed consent was obtained from the patients or a legal representative.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}